Randomised trial of SMS to improve testing for diabetes in women

  • Research type

    Research Study

  • Full title

    impRoving testing for cardiometabolic diseases in women with previous gestational diabetes mellitus: an exemplar study on implementation and evaluation of a novel dAta-DrIven rANdomised clinical Trial platform in primary care (RADIANT)

  • IRAS ID

    297067

  • Contact name

    Francesca Crowe

  • Contact email

    F.Crowe@bham.ac.uk

  • Sponsor organisation

    University of Birmingham

  • ISRCTN Number

    ISRCTN13791687

  • Duration of Study in the UK

    1 years, 2 months, 1 days

  • Research summary

    The way we usually test new ways of supporting health in the NHS is using randomised controlled trials (RCTs). Here, we randomly divide a group of people into two or more groups and give one group a new intervention and compare the effects between the groups.

    Finding and including patients in RCTS is usually done manually. Few of those who are suitable actually take part. This makes RCTs time-consuming, and it is hard to know if the intervention will work for everyone. This process can be streamlined by testing interventions using data which is routinely collected by electronic health systems. This approach can reduce the burden of taking part for both patients and health workers because we can easily select and invite suitable patients. Using these “data-enabled RCTs” also means we can follow up differences over time, to see whether the intervention has a lasting effect.

    We want to answer clinical questions by running a data-enabled RCT. We have found a current health problem: a lack of testing for diabetes in women who developed diabetes during pregnancy (we call this gestational diabetes mellitus or GDM for short).

    In collaboration with patients, we will develop a short animation explaining why it is important for women who had GDM to have yearly diabetes tests. We will send a text message with a link to the animation to women who had GDM, which encourages them to book a diabetes test with their GP.

    We will select women who have had GDM and who already receive text messages from their GP and randomly divide them into two groups. One group will receive the text message and animation, the other will not.

    We will collect anonymous information from electronic medical records to find out if more women who received the text message had diabetes tests.

  • REC name

    South Central - Hampshire B Research Ethics Committee

  • REC reference

    24/SC/0069

  • Date of REC Opinion

    20 May 2024

  • REC opinion

    Further Information Favourable Opinion